Editorial Series
Search for
Sort by 
Page
Showing 1 - 14 of 14 documents.
The Cardiology Show
1 COMMENT - Nov 18, 2009 16:30 EST
Join Drs Valentin Fuster, Roger Blumenthal, Bob Harrington, Judith Hochman, Sanjay Kaul, Suzanne Oparil, Gregg Stone, Lynne Warner Stevenson, and Bruce Wilkoff as they discuss the results of ARBITER 6-HALTS, the PLATO STEMI subanalysis, the two CHAMPIONs, and CASCADE and tackle the issue of too little, too soon in clinical trials today.
Editorial series
Nov 11, 2009 09:50 EST
New agents and interventions are paving the way for revised modalities in the management of patients with atrial fibrillation. Join Drs Alpert and Delascio Lopes for a review of the latest findings and options.
Editorial series
Oct 30, 2009 12:35 EDT
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Editorial series
Oct 23, 2009 10:40 EDT
Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.
Editorial series
Oct 2, 2009 13:45 EDT
Join 'heartwire's Steve Stiles as he talks to Drs Nassir Marrouche and Clyde Yancy about MADIT-CRT, the potential benefits and costs for the heart-failure population in light of the trial, and about why the Europeans seem to be ahead of the guidelines in the European CRT Survey.
Editorial series
Sep 15, 2009 14:10 EDT
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
The Cardiology Show
Sep 2, 2009 11:15 EDT
Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.
Editorial series
8 COMMENTS - Jul 14, 2009 13:36 EDT
Join Drs Melissa Walton-Shirley, Ann Curtis, and Cindy Grines for an overview of PROTECT-AF and their thoughts on the future of the Watchman device.
Editorial series
Jun 5, 2009 09:30 EDT
Is it possible and desirable to envisage a nationwide system to screen athletes for hypertrophic cardiomyopathy? Drs Ommen, Maron, and Thompson examine the Italian screening data and review the implications of this model for the US.
The Cardiology Show
Apr 2, 2009 15:35 EDT
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
HeartWire clips
Dec 16, 2008 13:00 EST
Join theheart.org's forum moderator in these in-depth interviews filmed on location at major congresses
Ten years in review
1 COMMENT - Dec 3, 2008 14:30 EST
As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?
Cardiology panels
Jul 15, 2008 16:33 EDT
Join Dr Melissa Walton-Shirley as she talks to Drs Ileana Piña, Clyde Yancy, and cardiology fellow Eiran Gorodeski about the current state of treatment for decompensated congestive heart failure, why we need to remember the fundamentals, and some exciting data from the PROTECT-1 pilot study.
Cardiology panels
18 COMMENTS - Dec 17, 2007 12:00 EST
Join Dr Melissa Walton-Shirley as she talks to Drs Clyde Yancy and Roger Blumenthal about CORONA, RETHINQ, MASTER-1, and the AF/CHF trial and why sticking with the basics might be the best approach for congestive heart failure.

Search for
Sort by 
Page
Showing 1 - 14 of 14 documents.
button
Previews
Featured programs
Poll
Health risks of extended work hours warrant changing the way physicians’ shifts are scheduled in hospitals.
See: Another in-hospital CV risk marker: 24-hour shifts with overnight on-call duty
True
False

Inside: Arrhythmia/EP
Arrhythmia/EP
Oct 21, 2009 11:32 EDT
Dr. Anne Curtis offers 2 cases of high-risk patients who present with shortness of breath. How are these patients diagnosed and treated?
Arrhythmia/EP
Oct 16, 2009 09:05 EDT
Rate control, rhythm control, new drugs and devices for anticoagulation -- the armamentarium of treatment options is expanding rapidly. Drs. Yancy, Cannon, and Boehmer discuss the latest treatment modalities for patients with AF.
Arrhythmia/EP
Sep 28, 2009 14:20 EDT
The results of MADIT-CRT suggest patients with early stage (NYHA class I/II) symptomatic heart failure (HF) indicated for an implantable cardioverter defibrillator (ICD) may benefit from the addition of cardiac resynchronization therapy (CRT). How likely are these results to increase device implant rates? Take our poll and see how your colleagues responded.